Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
|Articles|May 2, 2018
- Pharmaceutical Technology-05-02-2018
- Volume 42
- Issue 5
PLC System With Wireless Connection
Ross, Charles & Son's SysCon’s programmable logic controller (PLC) system features a control panel with a wireless connection that allows users to access the PLC system using tablets, laptops, and smartphones via Ethernet, WLAN, or Bluetooth.
SysCon’s programmable logic controller (PLC) system features a control panel with a wireless connection. The wireless connection allows users to access the PLC system using tablets, laptops, and smartphones via Ethernet, WLAN, or Bluetooth.
The wireless connection has a 100-meter range that allows users to move freely on the job site. The panel can be controlled from non-hazardous and hazardous locations, including Class 1 Division 1, using a company-provided tablet that has a 12-hour battery life. Additional tablets are available for multiple shift applications.
Other features include fan and ventilation kit, light tree with audible alarm functions, color touch screen human machine interface, and USB ports for data acquisition in a comma-separated value format.
SysCon is a full-scale machine and controls fabrication facility owned by Ross, Charles & Son.
Articles in this issue
over 8 years ago
Microfluidics Platform for Drug Encapsulationover 8 years ago
Pipette Tip for Highly Viscous Liquidsover 8 years ago
Hygienic Magnetic Mixerover 8 years ago
The Role of Carriers in DPI Capsulesover 8 years ago
Freeze-Drying Process Optimizationover 8 years ago
Harmonizing GMP Inspectionsover 8 years ago
Improving Visual Inspectionover 8 years ago
How to Plan Smoke Studiesover 8 years ago
Integrated Systems Aid Data Integrityover 8 years ago
Key Ingredients to Healthcare’s FutureRelated to this article
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Richard Jaenisch examines whether FDA's NAM pathway truly shortens drug pipelines or just shifts the evidentiary burden elsewhere.
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.